|
Oct 24
|
3 Absurdly Cheap Stocks That Pay High Dividends
|
|
Oct 23
|
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today
|
|
Oct 22
|
Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024
|
|
Oct 18
|
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
|
|
Oct 18
|
Gilead withdraws bladder cancer drug in US after failed trial
|
|
Oct 18
|
High Growth Tech Stocks to Watch in October 2024
|
|
Oct 17
|
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
|
|
Oct 15
|
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
|
|
Oct 14
|
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket
|
|
May 4
|
23 Most Profitable Stocks of the Last 12 Months
|
|
May 3
|
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
|
|
May 3
|
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
|
|
May 2
|
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
|
|
Apr 30
|
Gilead Sciences to Present at Upcoming Investor Conferences
|
|
Apr 30
|
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
|
|
Apr 29
|
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Apr 29
|
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
|
|
Jan 16
|
Gilead Sciences with Emma's Story: Self-Advocacy in Breast Cancer
|
|
Jan 12
|
Gilead Sciences Inc's Chief Commercial Officer Johanna Mercier Sells 8,242 Shares
|
|
Jan 11
|
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
|